Skip to content
naulon
Not checkedNot checked for notices yet.

Reproductive issues in carriers of germline pathogenic variants in the BRCA1/2 genes: an expert meeting

Barbara Buonomo, Claudia Massarotti, Miriam Dellino and 7 more

BMC Medicine · 2021

doi:10.1186/s12916-021-02081-7 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Background Healthy individuals and patients with cancer who are carriers of germline pathogenic variants in the BRCA1/2 genes face multiple reproductive challenges that require appropriate counseling and specific expertise. Main body On December 5th–7th, 2019, patient advocates and physicians with expertise in the field of reproductive medicine, fertility preservation, and oncology were invited to “San Giuseppe Moscati” Hospital in Avellino (Italy) for a workshop on reproductive management of women with germline pathogenic variants in the BRCA1/2 genes. From the discussion regarding the current evidence and future prospective in the field, eight main research questions were formulated and eight recommendations were developed regarding fertility, fertility preservation, preimplantation genetic testing, and pregnancy in healthy carriers and patients with cancer. Conclusion Several misconceptions about the topic persist among health care providers and patients often resulting in a discontinuous and suboptimal management. With the aim to offer patient-tailored counseling about reproductive issues, both awareness of current evidences and research should be promoted.

Abstract licence: CC BY-NC-ND

References116

    40 more references, whose wording the paper’s licence keeps private.

    All 116 references

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.